0
发表咨询在线!
中文簡介
《歐洲藥學和生物藥理學雜志》提供了一個出版來自制藥技術、制藥生物技術和生物藥理學領域的新穎和創新研究的媒體。主題包括:?藥物和藥物前設計、藥物穩定性和藥物開發?藥物和生物制藥的開發、配方和制造?物理制藥、藥物傳遞系統、控制釋放系統和藥物靶向?生物藥劑學?藥物分析和藥物包裝?質量控制、GMP和法規方面?醫療設備“三的規則”編輯和編輯委員會制定了“3的規則”。在投稿前，作者必須考慮以下三個標準，并在工作中設定完整的編輯審核流程:1. 這篇論文必須報道在制藥技術、生物制藥和重要的制藥生物技術方面的最新進展2. 一篇論文必須基于深入和廣泛的研究，使用已建立的或描述良好的方法，包括適當的控制。研究必須是假設驅動的，結論必須得到數據的支持。3.手稿中描述的研究必須代表一種新穎的方法這些規則也被用作同行審稿的指導方針。請按此瀏覽“規則三”
英文簡介
The European Journal of Pharmaceutics and Biopharmaceutics provides a medium for publication of novel and innovative research from the areas of Pharmaceutical Technology, Pharmaceutical Biotechnology and Biopharmaceutics.Topics covered include:? Drug and pro-drug design, drug stability and drug development? Development, formulation and manufacturing of pharmaceuticals and biopharmaceuticals? Physical pharmacy, drug delivery systems, controlled release systems and drug targeting? Biopharmaceutics? Pharmaceutical analysis and pharmaceutical packaging? Quality control, GMP and regulatory aspects? Medical devices"The Rules of 3"The Editors and Editorial board have developed the "Rules of 3". Authors must consider the following three criteria before they submit a manuscript and set the whole process of editing and reviewing at work:1. The paper must report on recent advances in pharmaceutical technology, biopharmaceutics and pharmaceutical biotechnology of major importance2. A paper must be based on a thorough and extensive study, using established or well-described methods and including proper controls. Research must be hypothesis-driven and conclusions must be supported by the data presented.3. The study described in the manuscript must represent a novel approachThe rules are also used as guidelines for the peer review of manuscripts. CLICK HERE to view the "Rules of 3".
近年期刊影響因子趨勢圖
相關醫學SCI期刊推薦
